Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Innhold levert av Harvard Innovation Labs. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Harvard Innovation Labs eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
Harvard Innovation Labs Stories: David Raiser - Aldatu Biosciences
M4A•Episoder hjem
Manage episode 177804574 series 1211262
Innhold levert av Harvard Innovation Labs. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Harvard Innovation Labs eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
David Raiser is the CEO and co-founder of Aldatu Biosciences, a company that has developed drug resistance diagnostics for HIV patients. Raiser holds a Ph.D. in Genetics from Harvard Medical School, while his co-founder and Aldatu's CSO Iain MacLeod has a plethora of degrees — including a Ph.D. in Pathology from the University of Cambridge— as well as an academic appointment at the Harvard School of Public Health AIDS Initiative. Together, the pair is leading a push for better, more affordable diagnostics tools, not only for HIV-related applications but also for other infectious diseases, in order to improve the quality of patient care and the cost of healthcare.
…
continue reading
12 episoder
M4A•Episoder hjem
Manage episode 177804574 series 1211262
Innhold levert av Harvard Innovation Labs. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Harvard Innovation Labs eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
David Raiser is the CEO and co-founder of Aldatu Biosciences, a company that has developed drug resistance diagnostics for HIV patients. Raiser holds a Ph.D. in Genetics from Harvard Medical School, while his co-founder and Aldatu's CSO Iain MacLeod has a plethora of degrees — including a Ph.D. in Pathology from the University of Cambridge— as well as an academic appointment at the Harvard School of Public Health AIDS Initiative. Together, the pair is leading a push for better, more affordable diagnostics tools, not only for HIV-related applications but also for other infectious diseases, in order to improve the quality of patient care and the cost of healthcare.
…
continue reading
12 episoder
كل الحلقات
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.